Incannex Healthcare Inc. (IXHL)
NASDAQ: IXHL · Real-Time Price · USD
0.4106
+0.0070 (1.73%)
At close: Dec 24, 2025, 1:00 PM EST
0.4115
+0.0009 (0.22%)
After-hours: Dec 24, 2025, 4:59 PM EST
Incannex Healthcare Employees
Incannex Healthcare had 12 employees as of June 30, 2025. The number of employees increased by 3 or 33.33% compared to the previous year.
Employees
12
Change (1Y)
3
Growth (1Y)
33.33%
Revenue / Employee
$1,000
Profits / Employee
-$3,989,333
Market Cap
142.16M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 12 | 3 | 33.33% |
| Jun 30, 2024 | 9 | 6 | 200.00% |
| Jun 30, 2021 | 3 | 1 | 50.00% |
| Jun 30, 2020 | 2 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
IXHL News
- 22 days ago - Incannex Granted FDA Fast Track Designation for IHL-42X in Obstructive Sleep Apnea (OSA) - GlobeNewsWire
- 5 weeks ago - Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 1Q 2026 - Newsfile Corp
- 2 months ago - Incannex Provides Shareholder Update Highlighting Clinical Progress, Capital Discipline, and EOY 2025 Strategic Focus - GlobeNewsWire
- 2 months ago - Incannex Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement - GlobeNewsWire
- 4 months ago - Incannex Reports Positive Results from Phase 2 Clinical Trial of PSX-001 (Psi-GAD) for Generalised Anxiety Disorder - GlobeNewsWire
- 4 months ago - Incannex Healthcare Authorizes $20 Million Share Repurchase Program - GlobeNewsWire
- 4 months ago - Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 3Q 2025 - Update - Newsfile Corp
- 4 months ago - Incannex Receives Positive Patient-Reported Outcomes and Compelling Phase 2 Efficacy Data for IHL-42X in Obstructive Sleep Apnoea - GlobeNewsWire